Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2022 Q2- Text added to 2022 Q3
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. senior Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. senior Avg
|
New words:
abiraterone, acetate, advice, aggressively, ascertainable, bankruptcy, baseline, biopharma, bone, bridge, censored, Chapter, chosen, clarity, compression, created, crossed, cutoff, cycle, debtor, delisting, docetaxel, Dr, EANM, eleven, enterprise, enzalutamide, favored, fracture, framework, gallbladder, Gillian, GlaxoSmithKline, good, goodwill, grace, GSK, hampered, harm, immature, increasingly, IRR, JCO, Kidney, led, likelihood, Lindsey, literature, LOH, losing, lymphopenia, magnitude, marrow, men, nested, nonpayment, notified, past, Paul, PDUFA, poor, possession, PR, Precision, pretreated, promising, reiterated, retire, Rolfe, scenario, SD, sector, signifying, spinal, stable, succeed, supervised, toxicity, traditionally, twelve, unreasonable, withdrew, workforce, Zejula
Removed:
achieve, adequate, advance, asserted, assume, assuming, award, budgeted, caption, cell, cervical, Chancery, Delaware, dependent, derivative, earliest, encouraging, forecasting, formed, iii, incrementally, insufficient, investigation, iv, key, larger, Macalinao, McKenry, meaningful, mediation, motion, NaN, proceeding, proposal, protocol, putative, settlement, shareholder, SLC, stability, stipulation, underway, variety
Valuein 2022 Q2 filing- Value in 2022 Q3 filing
Original filings
Filing view